Related references
Note: Only part of the references are listed.ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia The CAPTIVATE Randomized Trial
Marijn C. Meuwese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Carotid Atherosclerosis Progression and ACAT Inhibition
Paolo Parini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality:: a population-based prospective study
Eva Warensjoe et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme
Taichi Ohshiro et al.
JOURNAL OF ANTIBIOTICS (2008)
Identification of the interaction site within acyl-CoA: Cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A
Akash Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice
Thomas A. Bell et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels
Mami Ikenoya et al.
ATHEROSCLEROSIS (2007)
ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice
Naoki Terasaka et al.
ATHEROSCLEROSIS (2007)
Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes
Taichi Ohshiro et al.
JOURNAL OF ANTIBIOTICS (2007)
Potential therapeutics for obesity and atherosclerosis: Inhibitors of neutral lipid metabolism from microorganisms
Hiroshi Tomoda et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Liver-specific inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice
Thomas A. Bell et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Effect of ACAT inhibition on the progression of coronary atherosclerosis
SE Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The forgotten majority - Unfinished business in cardiovascular risk reduction
P Libby
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages
DE Dove et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness
AT Lada et al.
JOURNAL OF LIPID RESEARCH (2004)
Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages
I Namatame et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effects of the acyl coenzyme A:: Cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions
JC Tardif et al.
CIRCULATION (2004)
ACAT2 is localized to Hepatocytes and is the major cholesterol-esterifying enzyme in human liver
P Parini et al.
CIRCULATION (2004)
Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation
KH Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice
EL Willner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages
S Fazio et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice
KK Buhman et al.
NATURE MEDICINE (2000)
Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100
MM Véniant et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia
H Yagyu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1
M Accad et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
